biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Flooredon Mar 07, 2014 2:08pm

132 Views

Post# 22295765

RE:RE:RE:RE:RE:RE:RE:RE:Bullish 3 Box Reversal - Target $5.38

Thankyou for proving my point oil. Your taunts don't interest me.

I agree that we need news or heads up.

You have been reported. And now on ignore from me so you can call me all the names you like until [hopefully] the Bullboard admin removes you.

GLTA (...except oil)

Bullboard Posts

FE Battery Metals begins 2024 winter drill program